AMN Healthcare Services, Inc.
HealthcareNYSE:AMN · New York Stock Exchange
+$0.01 today
Vol 0.62M · Avg 1.02M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-14.9%
avg 16.1%
ROIC
2.1%
avg 10.5%
ROA
-4.6%
avg 6.3%
Analysis
ROIC is currently the strongest return metric at 2.1% versus its period average of 10.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Caroline Sullivan Grace | President, Chief Executive Officer & Director | $2.31M | — | 57 | $129,923.00 | 0.33% |
Brian Scott | Chief Financial Officer & Chief Operating Officer | $1.25M | — | 56 | $81,840.00 | 0.21% |
Christopher S. Schwartz | Chief Accounting Office & Controller | $1.20M | — | — | $47,495.00 | 0.12% |
Mark Christopher Hagan | Chief Information & Digital Officer | $1.05M | — | 58 | $21,598.00 | 0.06% |
Whitney Laughlin | Corporate Secretary & Chief Legal Officer | $864,534.00 | — | 56 | $23,652.00 | 0.06% |
Nishan Sivathasan | Division President of Technology and Workforce Solutions | — | — | — | — | — |
Randle G. Reece | Senior Director of Investor Relations & Strategy | — | — | — | $8,304.00 | 0.02% |
Kerry Perez | Chief Marketing Officer | — | — | — | — | — |
Robin Johnson | Group President of Nursing & Allied Solutions | — | — | — | — | — |
Julie Macdonald | Chief Communications Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +65.6% | -2.1% (13yr)2 analysts |
| Revenue | N/A | N/A | +15.3% | +4.9% (13yr)2 analysts |
| Net Income | N/A | N/A | +68.4% | N/A2 analysts |
| EBIT | N/A | N/A | +34.2% | +1.2% (13yr)2 analysts |
Analysis
Recent growth has been strongest in Net Income at +68.4% over three years. Forward estimates point to Revenue at +4.9% (13yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Butterfly Network, Inc.
NYSE:BFLY
$1.45B
COMPASS Pathways plc
NASDAQ:CMPS
$1.16B
Nutex Health, Inc.
NASDAQ:NUTX
$859.80M
HealthStream, Inc.
NASDAQ:HSTM
$763.39M
Replimune Group, Inc.
NASDAQ:REPL
$733.24M
Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
$722.58M
Evolent Health, Inc.
NYSE:EVH
$539.91M
Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
$515.41M
Myriad Genetics, Inc.
NASDAQ:MYGN
$408.96M
AirSculpt Technologies, Inc.
NASDAQ:AIRS
$377.42M
Who manages AMN?
AMN Healthcare Services, Inc. (AMN) lists 10 active executives. The top listed executive is Brian Scott, Chief Financial Officer & Chief Operating Officer.
Are AMN insiders buying or selling?
Recent insider activity shows net buying of $812,533.78.
Explore More
Continue the stock analysis
Jump to another research area for this company.